COHERUS BIOSCIENCES, INC. 11,764,706 Shares of Common Stock Underwriting AgreementCoherus BioSciences, Inc. • May 18th, 2023 • Biological products, (no disgnostic substances) • New York
Company FiledMay 18th, 2023 Industry JurisdictionCoherus BioSciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 11,764,706 shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,764,705 shares of Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock.”